Atomic AI
Latest round
- Series A
Last raised
- Nov 2022
Total raised
- $43M
Investors
- 8
About Atomic AI
a. Atomic AI is a biotech company that leverages artificial intelligence (AI) technology on molecular structures for reengineering RNA biology to create chemicals and pharmaceuticals. In January 2023, Atomic AI, Inc. The company has developed a proprietary AI-driven 3D RNA structure engine for discovering novel structure targets across the transcriptome and for designing RNA-targeted small molecules, RNA-based medicines, and RNA tools. The engine can predict structured, ligand-able RNA motifs at a good speed, which has been a barrier to current approaches in RNA drug discovery.
Who invested in Atomic AI
8 investors across 2 rounds
See all investors in Atomic AI
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Atomic AI
Who invested in Atomic AI?
Atomic AI has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Atomic AI raised?
Atomic AI has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Atomic AI last raise money?
Atomic AI's most recent round on record is a Series A, in Nov 2022.
What does Atomic AI do?
Atomic AI is a biotechnology company.
Where is Atomic AI headquartered?
Atomic AI is headquartered in South San Francisco, US.
Which VCs invest in companies like Atomic AI?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Atomic AI's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Atomic AI? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.